Close Menu

NEW YORK – Documents related to two patent infringement lawsuits brought by Guardant Health have revealed new information about the litigation strategies being pursued by both the plaintiff and the two defendants, Personal Genome Diagnostics and Foundation Medicine.

Guardant said it believes Foundation and Personal Genome Diagnostics (PGDx) have been coordinating to invalidate patents held by Guardant and have a joint defense agreement to that effect.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.